Navigation Links
Visikol Whole Rodent Brain Tissue Clearing and Imaging Services
Date:5/15/2019

The conventional method for characterizing brain tissues has always been the process of histology wherein tissues are cut into ultra-thin two-dimensional slices, placed on glass microscope slides and qualitatively evaluated after staining. The problem with this approach in the context of the brain is that the brain is a highly heterogenous and complex tissue that is challenging to evaluate using very thin sections. This led to the introduction of tissue clearing techniques which when combined with fluorescent labeling and 3D microscopy have allowed for the complete three-dimensional characterization of tissues.

“The problem with these approaches is that they are incredibly challenging to execute as they require the mastery of several disciplines and thus many researchers have struggled to implement them for routine use. At Visikol, we have developed a high-throughput workflow for transforming these tissues into three-dimensional data sets which allows our Clients to easily acquire complex three-dimensional insights from their tissues,” described Visikol CSO Dr. Thomas Villani. To allow for this workflow, Visikol has developed its patented Visikol® HISTO™ tissue clearing approach which is not only rapid and compatible with most labeling techniques, but also reversible which allows for follow up validation.

“While the original CLARITY technique received a lot of media attention, the Visikol® HISTO™ technology was actually developed first and unlike the CLARITY technique, the Visikol® HISTO™ technique can be reversed such that it can be validated against gold-standard histology for use in clinical and translational applications. Our pharmaceutical Clients find this validation critical and this is one of the key attributes which has allowed it to become a standardized tool for 3D tissue imaging,” described Dr. Villani.

Visikol works with ten of the top twenty pharmaceutical companies today on their drug discovery and development efforts and characterizes brain tissues for a wide range of applications. “I believe what truly differentiates us in this space is that we have developed a practical approach to 3D tissue imaging that can be validated and automated for routine use. I find that a lot of researchers have tried to tackle 3D tissue imaging with incredibly expensive and complex protocols wherein our unique and practical approach dramatically improves throughput while reducing costs and providing the right level of detail,” explained Visikol CEO Dr. Michael Johnson.

Instead of degrading tissue morphology to achieve deep label penetration and waiting weeks or using low throughput light sheet microscopy, Visikol relies on a standardized and automated process that images 1 mm brain sections using confocal microscopy. “We find that very few of our Clients actually need to image whole rodent brains intact and this approach enables the same level of imaging quality as more complex procedures while providing reproducibility, lower costs and higher throughput,” described Visikol Director of Imaging Services Dr. Graeme Gardner. To work with Visikol on your next brain imaging project you can simply send along a fixed brain tissue for imaging and analysis using Visikol’s 3Screen™ image analysis software designed specifically for 3D analysis.

About Visikol
Visikol is a CRO focused on advanced drug discovery that is leading the fields of bio-imaging, bioinformatics and image analysis. We conduct end-to-end drug discovery services that include both 2D and 3D in vitro models and assays, 3D whole mount tissue imaging, digital pathology and custom drug discovery projects. Visikol offers a portfolio of drug discovery services ranging from 2D and 3D cell culture model and assay development to in vitro screening, animal tissue histology and automated image processing. The focus of these services is to transform tissues into images and ultimately into quantitative data sets that can be mined for actionable insights that help our Clients make more informed decisions during the drug discovery process. Additionally, Visikol manufactures and sells a suite of tissue clearing reagents and 3D immuno-labeling kits. These products allow researchers to easily and rapidly image whole tissues and 3D cell culture models in 3D instead of traditional 2D sectioning. For more information about Visikol or its services, please visit our website at visikol.com.

Read the full story at https://www.prweb.com/releases/visikol_whole_rodent_brain_tissue_clearing_and_imaging_services/prweb16307116.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Abcam Collaborates with Visikol to Develop New Tools for Improved Tissue Clearing and 3D Imaging
2. Visikol Releases Open Source 3Screen™ Python Library for Training Convolutional Neural Networks for Use in Digital Pathology
3. Come Visit Visikol at Society of Toxicology 2019 in Baltimore at Booth 3225
4. Visikol Launches OpenLiver™ 3D Cell Culture Models to Accelerate Drug Discovery
5. Biopredic International and Visikol Partner on Liver 3D Cell Culture Liver Development
6. Come Visit Visikol at SLAS to Learn About 3D Cell Culture Assays and Models
7. Visikol Appoints Pharmaceutical Industry Leader, Stewart Hunt, as Director of US Sales
8. Visikol Hits Key Milestone, Recognized by Forbes for Passion & Innovation
9. Visikol Co-Founder Michael Johnson named to 2017 Forbes 30 Under 30 List
10. Elyctis ID Reader Product Range Now Covers the Whole Citizen Journey Allowing to Read eID and ePassport Seamlessly in All Situations
11. MediaPlanet and Dante Labs Team Up to Highlight the Role of Whole Genome Sequencing within Rare Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/6/2019)... ... August 06, 2019 , ... The demand for plant-based ... in particular quickly entered the limelight – meat alternatives. Yet, to make these ... emulsifying ingredient such as methyl cellulose. This ingredient is highly synthetic. Having a ...
(Date:8/1/2019)... CAMBRIDGE, Mass. (PRWEB) , ... August 01, 2019 , ... ... announced by Johannes Fruehauf, MD, PhD, founder and president of BioLabs, which provides premier ... created the CFO role to strengthen our ability to forecast and manage growth,” says ...
(Date:8/1/2019)... ... 2019 , ... USDM Life Sciences (USDM) announces that Jay Crowley, Vice President ... addressing challenges with the upcoming EU MDR IVDR regulations . , ... variety of positions over his 26 years at the FDA, including developing the framework ...
Breaking Biology News(10 mins):
(Date:8/8/2019)... ... August 08, 2019 , ... Inference ... and service organizations, today announced that the company’s Studio Intelligent Virtual Agent (IVA) ... market . Inference will officially accept the award at Frost & Sullivan’s annual ...
(Date:8/6/2019)... ... August 06, 2019 , ... The ... the launch of a community project that will engage middle and early high ... project, entitled “A Youth-Led Citizen Science Network for Community Environmental Assessment.” Collaborative partners ...
(Date:7/19/2019)... ... 18, 2019 , ... Global precision motion and piezo technology ... motion facilities in Lederhose, Germany, increasing their current footprint by half again. , ... in addition to general office space, a significant increase to its existing 129,000ft² ...
(Date:7/11/2019)... ... July 11, 2019 , ... At the most recent ... regenerative therapies to eight military Veterans under the R3 Heroes Program. The Veterans included ... The R3 Heroes Program allow anyone to nominate a military Veteran, teacher or first ...
Breaking Biology Technology: